PREVIEW
Because osteoporosis management is a rapidly changing landscape, primary care physicians may not know what to tell their female patients about the best choice of therapy for them. Whether to take estrogen or one of the newer agents to reduce bone loss—that is the question. Drs Isenbarger and Chapin review the data on the available therapeutic agents and recommend an approach to prevention and treatment of this common disease of aging.